
Sign up to save your podcasts
Or
This week I speak with Woody Sankar, Professor of Orthopedic Surgery by the Perelman School of Medicine at the University of Pennsylvania and Director of the Hip Preservation Team at the Children's Hospital of Philadelphia
We talk about outcomes of open reduction for developmental dislocation of the hip and the study he recently co-authored, which was the result of a multicentre effort led by the global hip dysplasia registry.
We talk about measuring outcomes for open reduction of developmental dislocation. Focusing on three suboptimal outcomes, Redislocation, proximal femoral growth disturbance, and residual acetabular dysplasia
We talk about surgical volume and variability and the possibility of measuring the quality of surgery
The study indicated that the rate of residual acetabular dysplasia was significantly lower in patients undergoing concomitant pelvic osteotomy, and how this finding must be contextualized.
We discuss the future of research in hip dysplasia, including the possibility of conducting a randomized controlled trial.
Amongst other things
This week I speak with Woody Sankar, Professor of Orthopedic Surgery by the Perelman School of Medicine at the University of Pennsylvania and Director of the Hip Preservation Team at the Children's Hospital of Philadelphia
We talk about outcomes of open reduction for developmental dislocation of the hip and the study he recently co-authored, which was the result of a multicentre effort led by the global hip dysplasia registry.
We talk about measuring outcomes for open reduction of developmental dislocation. Focusing on three suboptimal outcomes, Redislocation, proximal femoral growth disturbance, and residual acetabular dysplasia
We talk about surgical volume and variability and the possibility of measuring the quality of surgery
The study indicated that the rate of residual acetabular dysplasia was significantly lower in patients undergoing concomitant pelvic osteotomy, and how this finding must be contextualized.
We discuss the future of research in hip dysplasia, including the possibility of conducting a randomized controlled trial.
Amongst other things